True Leaf’s 40-Acre Site Could Produce 125,000 Kilograms per Year
Ryan Allway
October 10th, 2017
Exclusive, News, Top News
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational marijuana next year. Ontario’s Finance Minister, Charles Sousa, warned that the demand could be so high that it would spark a shortage early on before licensed producers can pick up the slack. Health Canada has pledged to speed up its approval process, but it still takes up to a year for new producers to go live.
Many existing licensed producers – or late-stage applicants – have responded by rapidly expanding their production capacity.
For more information on True Leaf’s pending Regulation A+ offering, request the details at http://promo.cfnmedia.com/trueleaf.
True Leaf Options 40 Acres
True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) recently acquired an option to purchase the 40 acres of land that encompass its facility in Lumby, B.C. Once approved, its existing facility would produce 2,500 kilograms per year and the 40-acre property would enable them to expand to a 1,000,000 square foot facility. This would put them at the high end of what many other licensed producers are currently targeting for production.
| Company Name | Funded Sq. Ft. | Market Capitalization $CAN |
| Aphria Inc. | 1,000,000 | $1B |
| Aurora Cannabis Inc. | 895,000 | $1.1B |
| Organigram Holdings Inc. | 242,943 | $310M |
“This is a milestone for True Leaf,” said CEO Darcy Bomford in a recent press release that described the newly optioned property and its potential within the market. “This property gives us the capacity to expand to meet the increased demand that is widely expected. With government approvals, the size of this site could allow us to build a 1,000,000 square foot facility and produce more than 125,000 kilograms of cannabis.”
Unique Among Competitors
True Leaf Medicine is unique among licensed producers in that it’s dually-focused on cultivating cannabis for humans and producing hemp-based products for pets.
True Leaf Pets aims to capitalize on the $105 billion global pets market that includes $1.6 billion in spending on supplements and nutraceuticals. The company’s soft chews are formulated with hemp and other active ingredients to support hip and joint health, calming, and immune and heart support in animals. The True Hemp™ products are fully legal in the U.S. and are already widely sold through the U.S., Canada, parts of Europe and New Zealand.
True Leaf Medicine is focused on cultivating medical marijuana under Canada’s ACMPR program. After initially applying in July of 2013, the company is now at stage five of seven for its 32,000 square foot grow located on the 40 acre site. The company aims to be revenue-ready by next summer with the potential to generate upwards of $55 million per year at $8.80 per gram before factoring in its ambitious expansion plans.
Regulation A+ Offering
True Leaf Medicine is also unique in that it’s among the first cannabis companies to raise capital under Regulation A+ in the United States and Canada, and it’s perhaps the only Regulation A+ raise from a cannabis company selling legal products in both the US and Canada. The team is seeking to raise C$10 million through the offering to grow revenue at True Leaf Pet and advance its efforts to become a licensed producer in Canada under True Leaf Medicine. Regulation A+ makes it easy for anyone to purchase the company’s securities with a C$250 minimum.
For more information on True Leaf’s pending Regulation A+ offering, request the details at http://promo.cfnmedia.com/trueleaf.
Looking Ahead
True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) represents a compelling opportunity within the cannabis industry. With plans to expand to 1,000,000 square feet, the company could become one of the largest producers of medical cannabis in Canada. True Leaf Pet is also a unique opportunity to capitalize on the already-legal demand for cannabinoid supplements for pets.
For more information, visit the company’s website at www.trueleaf.com.
SEC Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that True Leaf Medicine Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.
No money or consideration is being solicited by the information on this website or any other communication and, if sent, money will not be accepted and will be promptly returned. No offer by a potential investor to buy our securities can be accepted and, if made, any such offer can be withdrawn before qualification of this offering by the SEC. A potential investor’s indication of interest does not create a commitment to purchase the securities we are offering. Any such indication of interest may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance is given and all other requirements to accept an investment from a potential investor are met after the offering qualification date.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.
Segra is a plant micropropagation (also known as “tissue culture”) company specializing in cannabis. Segra is focused on producing standardized cannabis plantlets on an industrial scale to meet global demand for clean, disease-free starting materials. The Company is currently developing cannabis micropropagation nurseries to serve large-scale producers in Canada and the US (California). In Canada, […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
